Balanced DietLab
News list
Regulatory2026.07.07

What TV exposés keep catching in supplement brands — one phrase can become a fine

What TV exposés keep catching in supplement brands — one phrase can become a fine

The ingredients were not the problem. Unapproved claims were.

TV investigative programs have recently zeroed in on supplement advertising, and public attention has focused on "which ingredient was the problem." Looking at the actual cases, though, the trigger is almost always not the ingredient itself but the wording used to describe its effect. This article names no specific broadcast or brand; it summarizes the recurring pattern and the rules behind it.

A recurring pattern: it's the wording, not the ingredient

In most flagged cases, the ingredient used in the product had been legally notified or recognized. The real issue was ad copy that stretched the ingredient's approved benefit into claims such as "prevents disease" or "has a treatment effect." Korea's pre-screening system — run by the Ministry of Food and Drug Safety (MFDS) and the Korea Health Functional Food Association — exists precisely to catch this: not the ingredient, but the claim.

Three types of claims the law prohibits

Article 8 of the Act on Labeling and Advertising of Foods, etc. prohibits (1) labeling or advertising that may be understood as claiming efficacy in preventing or treating disease, (2) labeling or advertising that may cause a food to be mistaken for a drug, and (3) labeling or advertising that may cause a non-health-functional food to be mistaken for a health functional food. The enforcement decree's Schedule 1 goes further: even without naming a disease, wording that merely "implies" a link to one is regulated.

  • Wording implying disease prevention or treatment efficacy
  • Wording implying the product can replace or enhance a drug's effect
  • Functional-food-level claims on a product that is not a certified health functional food
  • Ads that skipped pre-screening or deviated from the screened version

Why testimonial-style ads carry extra risk

In at least one administrative case, a brand cited human clinical test results but omitted conditions such as the test subjects' ethnicity and nationality, and was found not to have followed the association's requested correction. Testimonial and review-style ads are persuasive, but trimming or omitting the original test conditions raises the risk of being classified as a "false or exaggerated" claim.

Brand checkpoints

  • Did you draft ad copy alongside the formula, not after it?
  • Does the copy avoid words that directly or indirectly imply a disease or symptom?
  • When citing a human clinical test, did you keep the original conditions — subject count, duration, ethnicity?
  • Did you avoid using health-functional-food-only language on a functional food with claims (HFF) product?
  • Does the final published ad match the pre-screened version exactly?

Balanced DietLab reviews ad claims alongside formula design from the start, so brands don't have to pull ads or face penalties after launch over wording issues. Running OEM/ODM manufacturing, our AI Formula Lab, and pre-launch ad-claim review together lowers this risk before launch, not after.

References

Related notes